RSS

NHS

The National Institute for Health and Care Excellence (NICE) has given a positive recommendation for Crysvita (burosumab) to be used in the treatment of X-linked hypophosphataemia (XLH) in children and young people with growing bones. more

News

A new report from the Office of Health Economics (OHE) — commissioned by the Association of the British Pharmaceutical Industry (ABPI) — has revealed what health leaders believe to be the ten most important medicines in NHS history. more

News

In this online exclusive, David Fraser, product manager Lateral Flow Services at BBI Solutions, discusses how easily-accessible diagnostic options could help lessen the burden on global health services. more

Opinion

Health research is thriving in the UK with more people taking part in NHS clinical research than ever before, new figures from the National Institute for Health Research (NIHR) show. more

Analysis

This special episode of the MedTalk Podcast features interviews with two big names in the fields of pharma and digital health from the health and life sciences day of the Liverpool Business Festival. more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

In the last of a series of articles surrounding the Pfizer Healthcare Hub: London, founder and CEO of Illumr, Jason Lee, talks to reporter Reece Armstrong about the use of AI and data within healthcare. more

News

Revealing her insights, Dr Sheuli Porkess, deputy chief scientific officer of the Association of the British Pharmaceutical Industry (ABPI), has recently discussed celebrating 70 years of the NHS and the ABPI, how both have been working to advance me more

News

The National Institute for Health and Care Excellence (NICE) has published its positive guidance for the first selective interleukin (IL)-23 inhibitor to treat moderate to severe plaque psoriasis. more

News

A delegate of experts from the North of England will be showcasing their excellence in tackling antimicrobial resistance (AMR) to an international conference in Boston, Massachusetts, USA. more

News

Data and analytics company, GlobalData, has revealed that biosimilars to Humira will have significant uptake across Europe this year as a result of 10–20% lower prices compared with the originator brand. more

Analysis

The ‘Life Sciences Industrial Strategy: Who’s driving the bus?’ report has been published by the House of Lords Science and Technology Committee, recommending that the government should simplify its implementation arrangements. more

Analysis

The Medicines and Healthcare products Regulatory Agency (MHRA) has implemented changes to the licence for valproate medicines — Epilim, Depakote and generics used to treat epilepsy and bipolar disorder — in the interest of public safety. more

News

A new poll from YouGov has revealed that the majority of the British public will personally step up to help the NHS advance medical research and fight diseases of the future. more

Analysis

Following a series of papers, published in The Lancet and featuring contributions from Professor Martin Underwood of Warwick Medical School, the NHS has published recommended changes to the treatment of low back pain. more

News

Innovate UK, the country’s innovation agency, has awarded a grant to Aseptika and Zenzium for the development of a new home-based early warning system, using artificial intelligence (AI), for people with severe respiratory disease. more

News

London-based scientists have found a new blood test that may be able to quickly predict if a female patient is responding to the breast cancer drug, palbociclib, earlier that is possible with currently available tests. more

Technology

A new version of the model Clinical Trials Agreement (mCTA), aimed at speeding up clinical trials and medicines research, has been welcomed by life science leaders across the whole of the UK, according to the ABPI more

News

A final appraisal determination (FAD) has been issued by the National Institute for Health and Care Excellence (NICE), recommending routine NHS use of avelumab for the treatment of adults in England, Wales and Northern Ireland with mMCC more

News

A recent study has revealed that an estimated 237 million medication errors occur in the NHS in England yearly, which, in addition to avoidable adverse drug reactions (ADRs), account for many avoidable deaths. more

News